CN Patent

CN1887859A — 硫普罗宁氨基酸盐及其制备方法

Assigned to WUHAN YUANDA PHARMACEUTICAL GROUP CO Ltd · Expires 2007-01-03 · 19y expired

What this patent protects

本发明涉及一种用于治疗急慢性肝病药物的硫普罗宁氨基酸盐及其制备方法。它具有如下通式：本发明解决了硫普罗宁遇水容易氧化降解，遇热容易挥发和分解的的问题。本发明将硫普罗宁制备成氨基酸盐阻止了硫普罗宁与氧的结合，能够防止它的氧化。同时提高了药用物质的熔点，使它的热稳定性明显提高，因此使作为有效成分的药用物质的药效作用明显提高。本发明所制得的硫普罗宁氨基酸盐还可用于制备药物制剂。

USPTO Abstract

本发明涉及一种用于治疗急慢性肝病药物的硫普罗宁氨基酸盐及其制备方法。它具有如下通式：本发明解决了硫普罗宁遇水容易氧化降解，遇热容易挥发和分解的的问题。本发明将硫普罗宁制备成氨基酸盐阻止了硫普罗宁与氧的结合，能够防止它的氧化。同时提高了药用物质的熔点，使它的热稳定性明显提高，因此使作为有效成分的药用物质的药效作用明显提高。本发明所制得的硫普罗宁氨基酸盐还可用于制备药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number: CN1887859A
Jurisdiction: CN
Classification: —
Expires: 2007-01-03
Drug substance claim: No
Drug product claim: No
Assignee: WUHAN YUANDA PHARMACEUTICAL GROUP CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.